Trials / Completed
CompletedNCT03055026
Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.
Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer: a Randomized, Double Blind, Placebo-controlled Study.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 582 (actual)
- Sponsor
- Fadoi Foundation, Italy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rivaroxaban | Tablets |
| DRUG | Placebo | Tablets |
Timeline
- Start date
- 2017-05-03
- Primary completion
- 2021-07-09
- Completion
- 2021-09-06
- First posted
- 2017-02-16
- Last updated
- 2022-03-11
Locations
17 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03055026. Inclusion in this directory is not an endorsement.